In recognition of Care Partner Appreciation Month, PD Avengers, in partnership with AbbVie, has launched dedicated initiatives recognizing the vital contributions of care partners for people with Parkinson’s disease (PD) and address often-overlooked challenges they face, such as sleep.
TruScreen Group Limited (NZE:TRU) (ASX:TRU) is pleased to provide an update of its key markets and target markets.
REMOVE THE PAIN - UNLEASH THE POSSIBILITIES! Pain Relief International, a registered 501(c)(3) non-profit and global leader in sustainable, drug-free pain relief technology, is proud to announce its commitment to delivering life-changing pain relief to millions of Australians suffering from chronic conditions, including migraine headaches, menstrual pain, back pain, and more.
PayToMe.co, an award-winning AI-driven fintech marketplace and top 1% global startup through Startupbootcamp, has announced an innovative partnership with Boundarie.
GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.
Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address to be provided by Mr Neville Gardiner and the Investor Presentation to be provided by Dr Richard Lipscombe to shareholders.
